Á lódáil...
The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
BACKGROUND: Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson’s disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psor...
Na minha lista:
| Foilsithe in: | BMC Complement Altern Med |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223566/ https://ncbi.nlm.nih.gov/pubmed/28069007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1525-y |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|